Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing Revision: v3.6.5. This is a metadata update indicating the page version rather than any substantive content change.SummaryDifference0.0%

- Check11 days agoChange DetectedA '2017 ( U.S. NIH Grant/Contract )' entry was added to the study's identifiers, indicating NIH funding and placing it among the other study IDs.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5. This signals a newer version of the page rather than a content change.SummaryDifference0.0%

- Check40 days agoChange DetectedThe revision tag at the bottom of the page was updated to v3.6.4, indicating a newer version of the study record.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page's revision was updated to v3.6.3 from v3.6.2, indicating a minor update to the entry rather than substantive changes to the study details.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2 on the page, signaling a minor update to the ClinicalTrials.gov entry without changing the study details.SummaryDifference0.0%

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.